Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study.

Wang, Hu; Wen, Jun; Yang, Yang; Liu, Hailin; Wang, Song; Ding, Xiaoli; Zhou, Chunqiao; Zhang, Xuelin.

Afiliação

Wang H; Department of Pharmacy, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, China.
Wen J; Department of Pharmacy, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, China.
Yang Y; Department of Pharmacy, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, China.
Liu H; Department of Pharmacy, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, China.
Wang S; Department of Pharmacy, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, China.
Ding X; Department of Pharmacy, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, China.
Zhou C; Department of Pharmacy, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, China.
Zhang X; Department of Pharmacy, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, China.

Front Pharmacol ; 13: 1036208, 2022.

Article em En | MEDLINE | ID: mdl-36467060